Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver with high
morbidity and mortality rates worldwide. Since 1963, when alpha-fetoprotein (AFP) was …

Simple Summary Liver cancer is a major health problem worldwide, and its early detection
and management are imperative for improving patient outcomes. Biomarkers have great …

Hepatocellular carcinoma (HCC) is a fatal disease occurring worldwide and developing
mainly in chronic liver diseased patients. Despite routine screening of individuals at high …

Hepatocellular carcinoma (HCC) is a significant cause of morbidity and mortality worldwide.
Despite significant advancements in detection and treatment of HCC, its management …

Background Liver hepatocellular carcinoma (HCC) is the third most common cause of death
by cancer and has a high mortality world-widely. Approximately 75–85% of primary liver …

Hepatocellular carcinoma (HCC) is an aggressive liver cancer but clinically validated
biomarkers that can predict natural history of malignant progression are lacking. The present …

The high mortality rate of hepatocellular carcinoma (HCC) is primarily due to its late
diagnosis. In the past, numerous attempts have been made to design genetic biomarkers for …

Purpose Hepatocellular carcinoma (HCC) is characterized by a poor long-term prognosis
and high mortality rate. Serum alpha-fetoprotein (AFP) levels show great prognostic value in …

Introduction: Hepatocellular carcinoma (HCC) is the most common primary liver cancer and
the third cancer-related cause of death worldwide. In recent years, several systemic therapy …

Hepatocellular carcinoma is one of the most deadly liver malignancies found worldwide,
with hepatitis virus infection being the prominent risk factor for this lesion. Patients with …